Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

72 ta ish

Ish: Lipid clinics worldwide: harmonization and guidance on how to optimally organize and fund. European Atherosclerosis Society consensus statement across 55 countries and more than 500 lipid clinics

  1. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019

    Gregory A. Roth, George A. Mensah, Catherine O. Johnson +71

    Sharh maqolaOchiq kirishCardiovascular Health and Risk FactorsJournal of the American College of Cardiology202012 iqtibos
    ABI

  2. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

    Frank L.J. Visseren, François Mach, Yvo M. Smulders +97

    MaqolaOchiq kirish20219 iqtibos
    ABI

  3. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society

    Børge G. Nordestgaard, M. John Chapman, Steve E. Humphries +26

    MaqolaOchiq kirish20138 iqtibos
    ABI

  4. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>

    François Mach, Colin Baigent, Alberico L. Catapano +87

    MaqolaOchiq kirish20198 iqtibos
    ABI

  5. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

    Colin Baigent, Anthony Keech, Patricia M. Kearney +8

    Sharh maqola20057 iqtibos
    ABI

  6. Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge

    William T. Friedewald, Robert I. Levy, Donald S. Fredrickson

    Maqola19727 iqtibos
    ABI

  7. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

    Deepak L. Bhatt, Philippe Gabríel Steg, Michael Miller +9

    Maqola20186 iqtibos
    ABI

  8. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

    Brian A. Ference, Henry N. Ginsberg, Ian Graham +23

    Sharh maqolaOchiq kirish20175 iqtibos
    ABI

  9. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement

    Florian Kronenberg, Samia Mora, Erik S.G. Stroes +19

    MaqolaOchiq kirish20225 iqtibos
    ABI

  10. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment

    Albert Wiegman, Samuel S. Gidding, Gerald F. Watts +29

    Sharh maqolaOchiq kirish20154 iqtibos
    ABI

  11. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

    M. Cuchel, Éric Bruckert, H. N. Ginsberg +41

    Maqola20143 iqtibos
    ABI

  12. Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

    Erik S.G. Stroes, Paul D. Thompson, Alberto Corsini +37

    Sharh maqola20153 iqtibos
    ABI

  13. Nonadherence to statins: individualized intervention strategies outside the pill box

    Peter Lansberg, André Lee, Zhen-Vin Lee +2

    Sharh maqola20183 iqtibos
    ABI

  14. The Clinical Genome Resource (ClinGen) Familial Hypercholesterolemia Variant Curation Expert Panel consensus guidelines for LDLR variant classification

    Joana Rita Chora, Michael A. Iacocca, Lukáš Tichý +25

    Maqola20213 iqtibos
    ABI

  15. Sarlavhasiz

    Boshqa3 iqtibos
    ABI

  16. Sarlavhasiz

    Boshqa3 iqtibos
    ABI

  17. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

    Christopher P. Cannon, Michael A. Blazing, Robert P. Giugliano +18

    MaqolaOchiq kirish20152 iqtibos
    ABI

  18. High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study

    Anne Langsted, Pia R. Kamstrup, Marianne Benn +2

    Maqola20162 iqtibos
    ABI

  19. Recommendations for reporting results of diagnostic genomic testing

    Zandra C. Deans, Joo Wook Ahn, Isabel M. Carreira +7

    Maqola20222 iqtibos
    ABI

  20. Equivalent Impact of Elevated Lipoprotein(a) and Familial Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease

    Berit Storgaard Hedegaard, Christian Sørensen Bork, Morten Kaltoft +5

    Maqola20222 iqtibos
    ABI

  21. 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance

    Marina Cuchel, Frederick J. Raal, Robert A. Hegele +20

    Maqola20232 iqtibos
    ABI

  22. High Lipoprotein(a) May Explain One-Quarter of Clinical Familial Hypercholesterolemia Diagnoses in Danish Lipid Clinics

    Berit Storgaard Hedegaard, Børge G. Nordestgaard, Helle Kanstrup +15

    Maqola20232 iqtibos
    ABI

  23. Proposal of a familial hypercholesterolemia paediatric diagnostic score (FH-PeDS)

    Jan Kafol, Beatriz Miranda, Rok Sikonja +11

    Maqola20252 iqtibos
    ABI

  24. Sarlavhasiz

    Boshqa2 iqtibos
    ABI

  25. Sarlavhasiz

    Boshqa2 iqtibos
    ABI